Ruckert, T., G. Andrieux, M. Boerries, K. Hanke-Muller, N. M. Woessner, S. Doetsch, C. Schell, K. Aumann, J. Kolter, A. Schmitt-Graeff, M. Schiff, L. M. Braun, E. Haring, S. Kissel, B. A. Siranosian, A. S. Bhatt, P. Nordkild, J. Wehkamp, B. A. H. Jensen, S. Minguet, J. Duyster, R. Zeiser, and N. Kohler. 2022. Human beta-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling. Sci Transl Med 14: eabp9675. doi: 10.1126/scitranslmed.abp9675.

Rush-Kittle, J., L. Gamez-Diaz, and B. Grimbacher. 2022. Inborn errors of immunity associated with defects of self-tolerance checkpoints: The CD28 family. Pediatr Allergy Immunol 33: e13886. doi: 10.1111/pai.13886.

Weissert, K., S. Ammann, T. Kogl, V. Dettmer-Monaco, C.  Schell, T. Cathomen, S. Ehl, and P. Aichele. 2022. Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH). EMBO Mol Med: e16085. doi: 10.15252/emmm.202216085.

Jacobsen, E. M., D. Fabricius, M. Class, F. Topfstedt, R. Lorenzetti, I. Janowska, F. Schmidt, J. Staniek, M. Zernickel, T. Stamminger, A. N. Dietz, A. Zellmer, M. Hecht, P. Rauch, C. Blum, C. Ludwig, B. Jahrsdorfer, H. Schrezenmeier, M. Heeg, B. Mayer, A. Seidel, R. Gross, J. Munch, F. Kirchhoff, S. F. N. Bode, G. Strauss, H. Renk, R. Elling, M. Stich, R.E. Voll, B. Tonshof, A. R. Franz, P. Henneke, K. M. Debatin, M. Rizzi, and A. Janda. 2022. High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection. Nat Commun 13: 7315. doi: 10.1038/s41467-022-35055-1.

Corrales, E., E. Levit-Zerdoun, P. Metzger, R. Mertes, A. Lehmann, J. Munch, S. Lemke, S. Kowar, and M. Boerries. 2022. PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma. Cell Commun Signal 20: 187. doi: 10.1186/s12964-022-00989-y.

Kraemer, A. N., A. L. Schafer, D. T. L. Sprenger, B. Sehnert, J. P. Williams, A. Luo, L. Riechert, Q. Al-Kayyal, H. Dumortier, J. D. Fauny, Z. Winter, K. Heim, M. Hofmann, M. Herrmann, G. Heine, R. E. Voll, and N. Chevalier. 2022. Impact of dietary vitamin D on immunoregulation and disease pathology in lupus-prone NZB/W F1 mice. Front Immunol 13: 933191. doi: 10.3389/fimmu.2022.933191.

Ferrarese, R., A. Izzo, G. Andrieux, S. Lagies, J. P. Bartmuss, A. P. Masilamani, A. Wasilenko, D. Osti, S. Faletti, R. Schulzki, S. Yuan, E. Kling, V. Ribecco, D. H. Heiland, S. Tholen, Prinz, G. Pelicci, B. Kammerer, M. Boerries, and M. S. Carro. 2023. ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma. Life Sci Alliance 6: e202201400. doi: 10.26508/lsa.202201400.

Locatelli, G., F. Marques-Ferreira, A. Katsoulas, V. Kalaitzaki, M. Krueger, B. Ingold-Heppner, S. Walthert, R. Sankowski, O. Prazeres da Costa, A. Dolga, M. Huber, M. Gold, C. Culmsee, A. Waisman, I. Bechmann, V. Milchevskaya, M. Prinz, A. Tresch, B. Becher, and T. Buch. 2022. IGF1R expression by adult oligodendrocytes is not required in the steady-state but supports neuroinflammation. Glia. doi: 10.1002/glia.24299. doi: 10.1002/glia.24299.

Carvalho LAR, Ross B, Fehr L, Bolgi O, Wöhrle S, Lum KM, Podlesainski D, Vieira AC, Kiefersauer R, Félix R, Rodrigues T, Lucas SD, Groß O, Geiss-Friedlander R, Cravatt BF, Huber R, Kaiser M, Moreira R. 2022. Chemoproteomics-Enabled Identification of 4-Oxo-β-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9. Angew Chem Int Ed Engl. 61(47):e202210498. doi: 10.1002/anie.202210498.

Krausz, M., N. Mitsuiki, V. Falcone, J. Komp, S. Posadas-Cantera, H. M. Lorenz, J. Litzman, D. Wolff, M. Kanariou, A. Heinkele, C. Speckmann, G. Hacker, H. Hengel, L. Gamez-Diaz, and B. Grimbacher. 2022. Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency? Front Immunol 13: 1011646. doi: 10.3389/fimmu.2022.1011646.

Globig, A. M., V. Strohmeier, R. Surabattula, D. J. Leeming, M. A. Karsdal, M. Heeg, G. Kindle, S. Goldacker, C. von Spee-Mayer, M. Proietti, B. Bausch, D. Bettinger, M. Schultheiss, R. Thimme, D. Schuppan, and K. Warnatz. 2022. Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency. J Clin Immunol. pii: 10.1007/s10875-022-01319-0. doi: 10.1007/s10875-022-01319-0.

Gruninger, P. K., F. Uhl, H. Herzog, G. Gentile, M. Andrade-Martinez, T. Schmidt, K. Han, D. W. Morgens, M. C. Bassik, M. L. Cleary, O. Gorka, R. Zeiser, O. Gross, and J. Duque-Afonso. 2022. Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia. Cancer Gene Ther. pii: 10.1038/s41417-022-00491-0. doi: 10.1038/s41417-022-00491-0.

Carvalho, L. A. R., B. Ross, L. Fehr, O. Bolgi, S. Wohrle, K. M. Lum, D. Podlesainski, A. C. Vieira, R. Kiefersauer, R. Felix, T. Rodrigues, S. D. Lucas, O. Gross, R. Geiss-Friedlander, B. F. Cravatt, R. Huber, M. Kaiser, and R. Moreira. 2022. Chemoproteomics-Enabled Identification of 4-Oxo-beta-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9. Angew Chem Int Ed Engl 61: e202210498. doi: 10.1002/anie.202210498.

Bauer, J., N. Kohler, Y. Maringer, P. Bucher, T. Bilich, M. Zwick, S. Dicks, A. Nelde, M. Dubbelaar, J. Scheid, M. Wacker, J. S. Heitmann, S. Schroeder, J. Rieth, M. Denk, M. Richter, R. Klein, I. Bonzheim, J. Luibrand, U. Holzer, M. Ebinger, I. B. Brecht, M. Bitzer, M. Boerries, J. Feucht, H. R. Salih, H. G. Rammensee, S. Hailfinger, and J. S. Walz. 2022. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. Nat Commun 13: 6401. doi: 10.1038/s41467-022-33746-3.